CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Trends Analyst Outlook Journalist POV

49 hedge funds and large institutions have $463M invested in Crinetics Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$109M
2
+$77.9M
3
+$74.1M
4
O
OrbiMed
New York
+$54.8M
5
RCM
RA Capital Management
Massachusetts
+$48.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$109M
2
$77.9M
3
$74.1M
4
$54.8M
5
$48.7M
6
$15M
7
$12.4M
8
$12M
9
$7.1M
10
$5.73M
11
$5.73M
12
$4.8M
13
$4.3M
14
$4.06M
15
$3.76M
16
$3.53M
17
$3.37M
18
$2.72M
19
$2.19M
20
$2.18M
21
$1.72M
22
$1.42M
23
$1.03M
24
$895K
25
$701K
1
2